Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02169154 · ClinicalTrials.gov registry record · Phase 1
A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT02169154 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 36 participants.
The verdict
NCT02169154, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This research study is being conducted to investigate the skin irritancy potential of a new medication which contains two active ingredients (diclofenac and menthol) together in a gel formulation and is being developed to treat mild to moderate pain and inflammation, such as acute sport injuries, sprains and strains.
Interventions
- DRUG 0.9% Saline
- DRUG 1% Diclofenac Sodium
- DRUG 3% Menthol
- DRUG 0.09% Menthol
- DRUG 0.2% Sodium Lauryl Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2014-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02169154
The ClinicalTrials.gov registry entry for NCT02169154 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 0.9% Saline is the first listed.
NCT02169154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02169154 about?
NCT02169154 is a clinical study titled "A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel". This research study is being conducted to investigate the skin irritancy potential of a new medication which contains two active ingredients (diclofenac and menthol) together in a gel formulation and is being developed to treat mild to moderate pain and inflammation, such as acute sport injuries, sp...
What is the current status of trial NCT02169154?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2014-06-01. Estimated completion is 2014-07-01.
What interventions are being tested in trial NCT02169154?
The interventions under investigation include: 0.9% Saline (DRUG), 1% Diclofenac Sodium (DRUG), 3% Menthol (DRUG), 0.09% Menthol (DRUG), 0.2% Sodium Lauryl Sulfate (DRUG).
Who is sponsoring clinical trial NCT02169154?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.